C. M. R. Volla, D. Markovic´, S. R. Dubbaka, P. Vogel
FULL PAPER
1-Allyl-4-methoxybenzene (Table 2, Entry 10): Following the typical
experimental procedure, sulfonyl chloride 2 (0.1 g, 0.71 mmol,
1 equiv.) and 4-methoxyphenylmagnesium bromide (5c; 1.0 in
THF, 1.1 mL, 1.1 mmol, 1.5 equiv.) gave the product (96 mg, 91%)
as a colorless oil. 1H NMR (400 MHz, CDCl3): δ = 3.39 (d, J =
6.6 Hz, 2 H, CH2), 3.84 (s, 3 H, OMe), 5.08–5.16 (m, 2 H, olefinic),
5.96–6.07 (m, 1 H, olefinic), 6.90 (d, J = 8.6 Hz, 2 H, arom.), 7.16
(d, J = 8.6 Hz, 2 H, arom.) ppm. 13C NMR (100.6 MHz, CDCl3):
δ = 39.4, 55.3, 113.8, 115.4, 129.5, 132.1, 137.9, 158.0 ppm. MS
(CI, NH3): m/z (%) = 149 (8) [M + 1]+, 148 (100) [M]+, 133 (23)
[M – 15], 117 (41) [M – 31]+, 91 (31) [M – 57]+.
3.51 (m, 1 H, CH), 5.02–5.10 (m, 2 H, olefinic), 5.97- 6.07 (m, 1
H, olefinic), 7.09–7.15 (m, 4 H, arom.). MS (CI, NH3): m/z (%) =
147 (7) [M + 1]+, 146 (62) [M]+, 131 (100) [M – 15], 115 (18)
[M – 31]+, 91 (34) [M – 55]+.
1-(But-2-enyl)-4-methoxybenzene and 1-(But-3-en-2-yl)-4-methoxy-
benzene (Table 4, Entries 3 and 6):[43]
Method A: Following the typical experimental procedure, sulfonyl
chloride 3 (0.1 g, 0.65 mmol, 1 equiv.) and 4-methoxyphenylmagne-
sium bromide (5c; 0.5 in THF, 2.0 mL, 1.0 mmol, 1.5 equiv.) gave
the mixture of products (90 mg, 85%) as a colorless oil.
Method B: Following the typical experimental procedure, sulfonyl
chloride 4 (0.1 g, 0.65 mmol, 1 equiv.) and 4-methoxyphenylmagne-
sium bromide (5c; 0.5 in THF, 2.0 mL, 1.0 mmol, 1.5 equiv.) gave
the mixture of products (83 mg, 79%) as a colorless oil.
1-Undecene (Table 2, Entry 11): Following the typical experimental
procedure, sulfonyl chloride 2 (0.1 g, 0.71 mmol, 1 equiv.) and n-
octylmagnesium bromide (5j; 2.0 in Et2O, 0.55 mL, 1.1 mmol,
1.5 equiv.) gave the product (82 mg, 75%) as a colorless oil. 1H
NMR (400 MHz, CDCl3): δ = 0. 88–0.93 (m, 3 H, Me), 1.24–1.35
(m, 12 H, 6 CH2), 1.36–1.44 (m, 2 H, CH2), 2.07–2.10 (m, 2 H,
CH2), 4.92–5.06 (m, 2 H, olefinic), 5.78–5.90 (m, 1 H, olefinic)
ppm. 13C NMR (100.6 MHz, CDCl3): δ = 14.1, 22.7, 28.9, 29.2,
29.3, 29.5, 29.6, 31.9, 33.8, 114.07, 139.3 ppm. MS (CI, NH3): m/z
(%) = 154 (3) [M]+, 126 (6) [M – 28]+, 111 (14) [M – 43]+, 97 (31)
[M – 57]+, 83 (55) [M – 71]+, 69 (68) [M – 85]+, 55 (100)
[M – 99]+.
1
1-(But-2-enyl)-4-methoxylbenzene: H NMR (400 MHz, CDCl3): δ
= 1.73 (dq, J = 6.1, 1.2 Hz, 3 H, Me), 3.31 (d, J = 6.4 Hz, 2 H,
CH2), 3.83 (s, 3 H, OMe), 5.47–5.68 (m, 2 H, olefinic), 6.88 (d, J
= 8.6 Hz, 2 H, arom.), 7.14 (d, J = 8.6 Hz, 2 H, arom.).
1-(But-3-en-2-yl)-4-methoxylbenzene: 1H NMR (400 MHz, CDCl3):
δ = 1.39 (d, J = 7.1 Hz, 3 H, Me), 3.43–3.51 (m, 1 H, CH), 5.04–
5.11 (m, 2 H, olefinic), 6.00- 6.09 (m, 1 H, olefinic), 6.90 (d, J =
8.7 Hz, 2 H, arom.), 7.18 (d, J = 8.7 Hz, 2 H, arom.) ppm. MS
(CI, NH3): m/z (%) = 163 (13) [M + 1]+, 162 (99) [M]+, 147 (100)
[M – 15], 131 (45) [M – 31]+, 115 (50) [M – 47]+, 91 (79)
[M – 71]+.
1-(But-2-enyl)-2-methylbenzene[9] and 1-(But-3-en-2-yl)-2-methyl-
benzene (Table 4, Entries 1 and 4)[9]
Method A: Following the typical experimental procedure, sulfonyl
chloride 3 (0.1 g, 0.65 mmol, 1 equiv.) and o-tolylmagnesium chlo-
ride (5a; 1.0 in THF, 1.0 mL, 1.0 mmol, 1.5 equiv.) gave the mix-
ture of products (71 mg, 75%) as a colorless oil.
2-(2-Methylbenzyl)-2-propenyl Acetate (11a): Following the typical
experimental procedure, sulfonyl chloride 10 (0.3 g, 1.4 mmol,
1 equiv.) and o-tolylmagnesium chloride (5a; 1.0 in THF, 2.2 mL,
2.2 mmol, 1.5 equiv.) gave the product (205 mg, 72%) as a light
Method B: Following the typical experimental procedure, sulfonyl
chloride 4 (0.1 g, 0.65 mmol, 1 equiv.) and o-tolylmagnesium chlo-
ride (5a; 1.0 in THF, 1.0 mL, 1.0 mmol, 1.5 equiv.) gave the mix-
ture of products (68 mg, 72%) as a colorless oil.
yellow oil. IR (film): ν = 2926, 1737, 1372, 1225, 1028, 908, 743,
˜
631, 604, 530 cm–1. 1H NMR (400 MHz, CDCl3): δ = 2.10 (s, 3 H,
Me), 2.27 (s, 3 H, Me-arom.), 3.39 (s, 2 H, CH2), 4.54 (s, 2 H,
OCH2), 4.75 (br. s, 1 H, olefinic), 5.12 (br. s, 1 H, olefinic), 7.12–
7.17 (m, 4 H, arom.) ppm. 13C NMR (100.6 MHz, CDCl3): δ =
19.5, 20.8, 37.3, 67.0, 114.3, 125.9, 126.7, 129.9, 130.2, 136.5, 136.8,
142.4, 170.7 ppm. MS (CI, NH3): m/z (%) = 204 (9) [M]+, 162 (8)
[M – 42]+, 144 (70) [M – 60]+, 129 (100) [M – 75]+, 91 (15)
[M – 133]+. HRMS (ESI-TOF): calcd. for C13H16O2 205.1228;
found 205.1238.
1
1-(But-2-enyl)-2-methylbenzene: H NMR (400 MHz, CDCl3): δ =
1.73 (dq, J = 6.2, 1.4 Hz, 3 H, Me), 2.34 (s, 3 H, Me-arom.), 3.35
(dt, J = 6.3, 1.3 Hz, 2 H, CH2), 5.43–5.54 (m, 1 H, olefinic), 5.57-
5.66 (m, 1 H, olefinic), 7.14–7.21 (m, 4 H, arom.) ppm.
1
1-(But-3-en-2-yl)-2-methylbenzene: H NMR (400 MHz, CDCl3): δ
= 1.40 (d, J = 6.8 Hz, 3 H, Me), 2.39 (s, 3 H, Me-arom.), 3.70–
3.78 (m, 1 H, CH), 5.03–5.12 (m, 2 H, olefinic), 5.98- 6.10 (m, 1
H, olefinic), 7.14–7.21 (m, 4 H, arom.) ppm. MS (CI, NH3): m/z
(%) = 147 (8), [M + 1]+, 146 (54) [M]+, 105 (100), [M – 41]+, 91
(36) [M – 55]+.
2-(4-Methoxybenzyl)-2-propenyl Acetate (11b): Following the typi-
cal experimental procedure, sulfonyl chloride 10 (0.3 g, 1.4 mmol,
1 equiv.) and 4-methoxyphenylmagnesium bromide (5c; 0.5 in
THF, 4.4 mL, 2.2 mmol, 1.5 equiv.) gave the product (206 mg,
1-(But-2-enyl)-4-methylbenzene[41] and 1-(But-3-en-2-yl)-4-methyl-
67%) as a light yellow oil. IR (film): ν = 2933, 1740, 1510, 1373,
˜
benzene (Table 4, Entries 2 and 5):[42]
1245, 1177, 1035, 902, 808, 632, 574 cm–1. 1H NMR (400 MHz,
CDCl3): δ = 2.07 (s, 3 H, Me), 3.35 (s, 2 H, CH2), 3.81 (s, 3 H,
OMe), 4.48 (s, 2 H, OCH2), 4.96 (br. s, 1 H, olefinic), 5.11 (br. s, 1
H, olefinic), 6.84 (d, J = 8.9 Hz, 2 H, arom.), 7.10 (d, J = 8.9 Hz,
2 H, arom.) ppm. 13C NMR (100.6 MHz, CDCl3): δ = 21.1, 39.5,
55.4, 66.4, 113.8, 113.9, 129.8, 130.5, 143.6, 158.2, 170.8 ppm. MS
(CI, NH3): m/z (%) = 221 (4) [M + 1]+, 220 (34) [M]+, 159 (100)
[M – 61]+, 145 (80) [M – 75], 129 (63) [M – 91]+, 91 (25) [M – 129]+.
HRMS (ESI-TOF): calcd. for C13H16O3 221.1178; found 221.1182.
Method A: Following the typical experimental procedure, sulfonyl
chloride 3 (0.1 g, 0.65 mmol, 1 equiv.) and p-tolylmagnesium chlo-
ride (5b; 1.0 in THF, 1.0 mL, 1.0 mmol, 1.5 equiv.) gave the mix-
ture of products (78 mg, 82%) as a colorless oil.
Method B: Following the typical experimental procedure, sulfonyl
chloride 4 (0.1 g, 0.65 mmol, 1 equiv.) and p-tolylmagnesium chlo-
ride (5b; 1.0 in THF, 1.0 mL, 1.0 mmol, 1.5 equiv.) gave the mix-
ture of products (73 mg, 77%) as a colorless oil.
2-Methylene-1,3-dio-tolylpropane (13a): Following the typical ex-
perimental procedure, sulfonyl chloride 12 (0.2 g, 0.8 mmol,
1 equiv.) and o-tolylmagnesium chloride (5a; 1.0 in THF, 2.4 mL,
2.4 mmol, 3.0 equiv.) gave the product (142 mg, 75%) as a light
1
1-(But-2-enyl)-4-methylbenzene: H NMR (400 MHz, CDCl3): δ =
1.71 (dq, J = 6.0, 1.2 Hz, 3 H, Me), 2.35 (s, 3 H, Me-arom.), 3.31
(d, J = 6.3 Hz, 2 H, CH2), 5.47–5.66 (m, 2 H, olefinic), 7.09–7.15
(m, 4 H, arom.).
yellow oil. IR (film): ν = 2921, 1644, 1493, 1460, 1378, 896, 741,
˜
1
1
1-(But-3-en-2-yl)-4-methylbenzene: H NMR (400 MHz, CDCl3): δ 633, 541 cm–1. H NMR (400 MHz, CDCl3): δ = 2.22 (s, 6 H, Me-
= 1.48 (d, J = 7.0 Hz, 3 H, Me), 2.36 (s, 3 H, Me-arom.), 3.42–
arom.), 3.34 (s, 4 H, 2CH2), 4.60 (s, 2 H, olefinic), 7.11–7.17 (m, 8
6286
www.eurjoc.org
© 2009 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2009, 6281–6288